Triple-negative breast cancer (TNBC), a subgroup that lacks expression of hormone receptors and HER2, overlaps with basal-like breast cancer (BLBC), a subgroup that expresses cytokeratins and ...
The overall poor prognosis of patients with TNBC and/or BLBC and their tendency to relapse with distant metastases indicate a definite need for effective systemic therapies for this disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback